This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-362-3p | ABCA1 | 0.11 | 0.64379 | -0.05 | 0.8308 | miRanda | -0.27 | 0 | NA | |
2 | hsa-miR-362-3p | ABCA6 | 0.11 | 0.64379 | -0.41 | 0.30457 | miRanda | -0.49 | 1.0E-5 | NA | |
3 | hsa-miR-362-3p | ABCC9 | 0.11 | 0.64379 | -0.58 | 0.0487 | miRanda | -0.5 | 0 | NA | |
4 | hsa-miR-362-3p | ABCD2 | 0.11 | 0.64379 | -0.21 | 0.52359 | miRanda | -0.3 | 0.00143 | NA | |
5 | hsa-miR-362-3p | ACAN | 0.11 | 0.64379 | -0.41 | 0.10954 | miRanda | -0.17 | 0.02006 | NA | |
6 | hsa-miR-362-3p | ACER2 | 0.11 | 0.64379 | -0.48 | 0.01435 | miRanda | -0.19 | 0.00079 | NA | |
7 | hsa-miR-362-3p | ADAM28 | 0.11 | 0.64379 | -0.48 | 0.15863 | PITA | -0.24 | 0.01584 | NA | |
8 | hsa-miR-362-3p | ADAM33 | 0.11 | 0.64379 | -0.33 | 0.4232 | miRanda | -0.41 | 0.0005 | NA | |
9 | hsa-miR-362-3p | ADAMTS1 | 0.11 | 0.64379 | -0.39 | 0.09809 | miRanda | -0.3 | 0 | NA | |
10 | hsa-miR-362-5p | ADAMTS12 | 0.51 | 0.05114 | -0.4 | 0.28425 | mirMAP | -0.68 | 0 | NA | |
11 | hsa-miR-362-3p | ADAMTS4 | 0.11 | 0.64379 | -0.28 | 0.27653 | miRanda | -0.23 | 0.00078 | NA | |
12 | hsa-miR-362-3p | ADAMTSL1 | 0.11 | 0.64379 | -0.13 | 0.64223 | miRanda | -0.33 | 7.0E-5 | NA | |
13 | hsa-miR-362-3p | ADAMTSL4 | 0.11 | 0.64379 | -0.41 | 0.09478 | miRNATAP | -0.24 | 0.00059 | NA | |
14 | hsa-miR-21-3p | ADCY1 | 0.06 | 0.84434 | -0.69 | 0.01679 | mirMAP | -0.32 | 0.00949 | NA | |
15 | hsa-miR-362-3p | ADCY1 | 0.11 | 0.64379 | -0.69 | 0.01679 | miRanda | -0.32 | 0.00014 | NA | |
16 | hsa-miR-362-3p | ADCYAP1 | 0.11 | 0.64379 | -0.2 | 0.67185 | miRanda | -0.63 | 0 | NA | |
17 | hsa-miR-362-5p | ADCYAP1 | 0.51 | 0.05114 | -0.2 | 0.67185 | PITA; miRNATAP | -0.81 | 0 | NA | |
18 | hsa-miR-362-3p | ADD2 | 0.11 | 0.64379 | -0.98 | 0.01735 | PITA; miRanda | -0.55 | 0 | NA | |
19 | hsa-miR-362-5p | ADHFE1 | 0.51 | 0.05114 | 0.01 | 0.98351 | TargetScan; miRNATAP | -0.23 | 0.00496 | NA | |
20 | hsa-miR-21-3p | ADIPOQ | 0.06 | 0.84434 | -0.49 | 0.50915 | MirTarget | -1.45 | 0 | NA | |
21 | hsa-miR-362-5p | AFAP1 | 0.51 | 0.05114 | -0.16 | 0.3649 | mirMAP | -0.11 | 0.00028 | NA | |
22 | hsa-miR-362-3p | AFF4 | 0.11 | 0.64379 | -0.05 | 0.75124 | PITA | -0.12 | 0 | NA | |
23 | hsa-miR-362-3p | AGAP11 | 0.11 | 0.64379 | -0.07 | 0.78145 | miRanda | -0.18 | 0.01802 | NA | |
24 | hsa-miR-362-3p | AGPAT4 | 0.11 | 0.64379 | -0.78 | 0.00264 | MirTarget | -0.32 | 1.0E-5 | NA | |
25 | hsa-miR-362-5p | AGPAT4 | 0.51 | 0.05114 | -0.78 | 0.00264 | mirMAP | -0.52 | 0 | NA | |
26 | hsa-miR-362-3p | AHNAK | 0.11 | 0.64379 | -0.62 | 0.01795 | PITA; miRanda; miRNATAP | -0.22 | 3.0E-5 | NA | |
27 | hsa-miR-362-3p | AK5 | 0.11 | 0.64379 | -0.8 | 0.01153 | miRanda | -0.35 | 0.00012 | NA | |
28 | hsa-miR-21-3p | AKAP11 | 0.06 | 0.84434 | 0.24 | 0.18121 | MirTarget | -0.14 | 0.00369 | NA | |
29 | hsa-miR-362-3p | AKAP2 | 0.11 | 0.64379 | 0.17 | 0.40729 | PITA; miRNATAP | -0.25 | 1.0E-5 | NA | |
30 | hsa-miR-362-3p | AKT3 | 0.11 | 0.64379 | -0.59 | 0.01641 | miRanda | -0.42 | 0 | NA | |
31 | hsa-miR-362-5p | AKT3 | 0.51 | 0.05114 | -0.59 | 0.01641 | PITA; TargetScan; miRNATAP | -0.52 | 0 | NA | |
32 | hsa-miR-362-3p | ALCAM | 0.11 | 0.64379 | -0.18 | 0.41514 | miRanda | -0.1 | 0.04247 | NA | |
33 | hsa-miR-362-3p | ALDH1A2 | 0.11 | 0.64379 | -1.71 | 0.00293 | miRanda | -0.4 | 0.02021 | NA | |
34 | hsa-miR-362-5p | ALPK3 | 0.51 | 0.05114 | 0.32 | 0.37339 | mirMAP | -0.2 | 0.04828 | NA | |
35 | hsa-miR-21-3p | AMIGO2 | 0.06 | 0.84434 | -0.38 | 0.13272 | MirTarget | -0.46 | 1.0E-5 | NA | |
36 | hsa-miR-362-3p | AMOTL1 | 0.11 | 0.64379 | -0.76 | 0.00615 | MirTarget | -0.45 | 0 | NA | |
37 | hsa-miR-362-3p | ANGPTL2 | 0.11 | 0.64379 | -0.63 | 0.02845 | miRanda; miRNATAP | -0.44 | 0 | NA | |
38 | hsa-miR-362-5p | ANGPTL7 | 0.51 | 0.05114 | -0.6 | 0.16236 | miRNATAP | -0.81 | 0 | NA | |
39 | hsa-miR-362-3p | ANKRD44 | 0.11 | 0.64379 | -0.5 | 0.04561 | miRanda | -0.23 | 0.00135 | NA | |
40 | hsa-miR-362-3p | ANKRD6 | 0.11 | 0.64379 | -0.33 | 0.13971 | miRanda | -0.2 | 0.00215 | NA | |
41 | hsa-miR-362-3p | ANO1 | 0.11 | 0.64379 | -1.17 | 0.00028 | miRanda | -0.27 | 0.00287 | NA | |
42 | hsa-miR-362-3p | AP4S1 | 0.11 | 0.64379 | -0.09 | 0.55098 | miRanda | -0.12 | 0.00739 | NA | |
43 | hsa-miR-362-3p | APBA2 | 0.11 | 0.64379 | -0.62 | 0.01322 | miRanda; miRNATAP | -0.28 | 9.0E-5 | NA | |
44 | hsa-miR-362-3p | APBB1IP | 0.11 | 0.64379 | -0.53 | 0.06348 | miRanda | -0.33 | 8.0E-5 | NA | |
45 | hsa-miR-362-3p | APOOL | 0.11 | 0.64379 | 0.18 | 0.28233 | miRanda | -0.13 | 0.00821 | NA | |
46 | hsa-miR-362-3p | AR | 0.11 | 0.64379 | -0.72 | 0.08465 | miRanda | -0.59 | 0 | NA | |
47 | hsa-miR-21-3p | ARHGAP6 | 0.06 | 0.84434 | -0.1 | 0.77625 | MirTarget | -0.59 | 5.0E-5 | NA | |
48 | hsa-miR-362-3p | ARHGEF15 | 0.11 | 0.64379 | -0.54 | 0.00479 | miRanda | -0.22 | 5.0E-5 | NA | |
49 | hsa-miR-362-3p | ARHGEF6 | 0.11 | 0.64379 | -0.48 | 0.03477 | MirTarget; miRanda | -0.32 | 0 | NA | |
50 | hsa-miR-21-3p | ARL10 | 0.06 | 0.84434 | -0.13 | 0.63188 | mirMAP | -0.45 | 4.0E-5 | NA | |
51 | hsa-miR-362-3p | ARL10 | 0.11 | 0.64379 | -0.13 | 0.63188 | mirMAP | -0.33 | 1.0E-5 | NA | |
52 | hsa-miR-21-3p | ARL2BP | 0.06 | 0.84434 | 0.1 | 0.503 | MirTarget | -0.11 | 0.0001 | NA | |
53 | hsa-miR-362-3p | ARL4C | 0.11 | 0.64379 | -0.39 | 0.13323 | PITA | -0.32 | 0 | NA | |
54 | hsa-miR-362-3p | ARL4D | 0.11 | 0.64379 | 0.07 | 0.75696 | miRNATAP | -0.18 | 0.00433 | NA | |
55 | hsa-miR-362-3p | ARMC9 | 0.11 | 0.64379 | -0.32 | 0.03253 | miRanda | -0.12 | 0.00121 | NA | |
56 | hsa-miR-362-3p | ARNT2 | 0.11 | 0.64379 | -0.83 | 0.01329 | miRanda | -0.36 | 0.0002 | NA | |
57 | hsa-miR-362-3p | ASAP1 | 0.11 | 0.64379 | 0.16 | 0.3669 | miRanda | -0.11 | 0.00754 | NA | |
58 | hsa-miR-362-3p | ASXL2 | 0.11 | 0.64379 | -0.01 | 0.96811 | miRanda | -0.16 | 3.0E-5 | NA | |
59 | hsa-miR-362-5p | ASXL2 | 0.51 | 0.05114 | -0.01 | 0.96811 | mirMAP | -0.12 | 0.00097 | NA | |
60 | hsa-miR-362-3p | ATP10A | 0.11 | 0.64379 | -0.48 | 0.07791 | miRanda | -0.39 | 0 | NA | |
61 | hsa-miR-21-3p | ATP2B4 | 0.06 | 0.84434 | -0.34 | 0.13246 | mirMAP | -0.5 | 0 | NA | |
62 | hsa-miR-362-5p | ATP2B4 | 0.51 | 0.05114 | -0.34 | 0.13246 | miRNATAP | -0.41 | 0 | NA | |
63 | hsa-miR-21-3p | ATRNL1 | 0.06 | 0.84434 | -0.66 | 0.11603 | MirTarget | -1.42 | 0 | NA | |
64 | hsa-miR-362-3p | ATXN1 | 0.11 | 0.64379 | -0.19 | 0.22524 | MirTarget; PITA; miRanda; miRNATAP | -0.15 | 0 | NA | |
65 | hsa-miR-362-5p | ATXN1 | 0.51 | 0.05114 | -0.19 | 0.22524 | mirMAP | -0.18 | 0 | NA | |
66 | hsa-miR-362-3p | B3GALT1 | 0.11 | 0.64379 | -0.92 | 0.05694 | miRanda | -0.34 | 0.01452 | NA | |
67 | hsa-miR-362-3p | B3GNT9 | 0.11 | 0.64379 | -0.42 | 0.00761 | miRanda | -0.11 | 0.00601 | NA | |
68 | hsa-miR-362-3p | BAALC | 0.11 | 0.64379 | -0.56 | 0.07918 | miRanda | -0.44 | 0 | NA | |
69 | hsa-miR-21-3p | BACE1 | 0.06 | 0.84434 | -0 | 0.98214 | mirMAP | -0.29 | 0 | NA | |
70 | hsa-miR-362-3p | BAHCC1 | 0.11 | 0.64379 | -0.14 | 0.5649 | PITA; miRanda | -0.24 | 0.00056 | NA | |
71 | hsa-miR-362-3p | BCL6 | 0.11 | 0.64379 | -0.43 | 0.02067 | miRanda | -0.15 | 0.00147 | NA | |
72 | hsa-miR-362-3p | BEND4 | 0.11 | 0.64379 | -0.57 | 0.13158 | miRanda | -0.35 | 0.00126 | NA | |
73 | hsa-miR-362-3p | BEX4 | 0.11 | 0.64379 | -0.56 | 0.02756 | miRanda | -0.3 | 4.0E-5 | NA | |
74 | hsa-miR-362-3p | BHLHE22 | 0.11 | 0.64379 | -0.08 | 0.78042 | miRanda | -0.3 | 0.00045 | NA | |
75 | hsa-miR-362-3p | BMF | 0.11 | 0.64379 | 0.05 | 0.80648 | PITA; miRanda; miRNATAP | -0.11 | 0.03223 | NA | |
76 | hsa-miR-362-5p | BMP1 | 0.51 | 0.05114 | -0.2 | 0.27787 | mirMAP | -0.25 | 0 | NA | |
77 | hsa-miR-362-3p | BMP6 | 0.11 | 0.64379 | -0.95 | 0 | miRanda | -0.21 | 0.00048 | NA | |
78 | hsa-miR-362-3p | BMPR1B | 0.11 | 0.64379 | -1.56 | 0.00021 | MirTarget; miRanda | -0.58 | 0 | NA | |
79 | hsa-miR-362-3p | BMPR2 | 0.11 | 0.64379 | -0.08 | 0.64874 | MirTarget; PITA; miRanda; miRNATAP | -0.15 | 1.0E-5 | NA | |
80 | hsa-miR-362-5p | BNC2 | 0.51 | 0.05114 | -0.53 | 0.08426 | PITA | -0.64 | 0 | NA | |
81 | hsa-miR-362-3p | BTK | 0.11 | 0.64379 | -0.56 | 0.06441 | miRanda | -0.37 | 3.0E-5 | NA | |
82 | hsa-miR-362-3p | CACNA1B | 0.11 | 0.64379 | -1.82 | 0.00013 | MirTarget; miRNATAP | -0.39 | 0.00442 | NA | |
83 | hsa-miR-362-5p | CACNA1E | 0.51 | 0.05114 | -0.97 | 0.01412 | mirMAP | -0.52 | 0 | NA | |
84 | hsa-miR-21-3p | CACNA2D1 | 0.06 | 0.84434 | -0.85 | 0.05575 | mirMAP | -1.03 | 0 | NA | |
85 | hsa-miR-362-3p | CACNA2D1 | 0.11 | 0.64379 | -0.85 | 0.05575 | miRanda | -0.78 | 0 | NA | |
86 | hsa-miR-362-3p | CADM1 | 0.11 | 0.64379 | -0.57 | 0.06122 | PITA; miRanda; miRNATAP | -0.41 | 0 | NA | |
87 | hsa-miR-362-3p | CADM3 | 0.11 | 0.64379 | -0.5 | 0.33965 | miRanda | -0.76 | 0 | NA | |
88 | hsa-miR-362-3p | CALCRL | 0.11 | 0.64379 | -0.45 | 0.04092 | miRanda | -0.33 | 0 | NA | |
89 | hsa-miR-362-3p | CAMK2B | 0.11 | 0.64379 | -0.01 | 0.97166 | miRanda | -0.39 | 0.00026 | NA | |
90 | hsa-miR-362-5p | CAMK2B | 0.51 | 0.05114 | -0.01 | 0.97166 | miRNATAP | -0.43 | 3.0E-5 | NA | |
91 | hsa-miR-362-3p | CAMK4 | 0.11 | 0.64379 | -0.8 | 0.0051 | miRanda | -0.25 | 0.00198 | NA | |
92 | hsa-miR-21-3p | CAMLG | 0.06 | 0.84434 | 0.15 | 0.34489 | MirTarget | -0.1 | 0.00733 | NA | |
93 | hsa-miR-362-3p | CAPN14 | 0.11 | 0.64379 | -0.42 | 0.33347 | miRanda | -0.27 | 0.02922 | NA | |
94 | hsa-miR-362-3p | CASS4 | 0.11 | 0.64379 | -0.55 | 0.04983 | miRanda | -0.32 | 7.0E-5 | NA | |
95 | hsa-miR-362-5p | CBFA2T3 | 0.51 | 0.05114 | -2.08 | 0 | PITA | -0.43 | 0.00017 | NA | |
96 | hsa-miR-362-3p | CBLN2 | 0.11 | 0.64379 | 0.33 | 0.35314 | miRanda | -0.2 | 0.04895 | NA | |
97 | hsa-miR-362-3p | CBX6 | 0.11 | 0.64379 | -0.16 | 0.54398 | mirMAP | -0.3 | 0.00011 | NA | |
98 | hsa-miR-362-5p | CBX6 | 0.51 | 0.05114 | -0.16 | 0.54398 | mirMAP | -0.42 | 0 | NA | |
99 | hsa-miR-362-3p | CC2D2A | 0.11 | 0.64379 | 0.14 | 0.60106 | miRanda | -0.25 | 0.00089 | NA | |
100 | hsa-miR-362-3p | CCDC102B | 0.11 | 0.64379 | -0.36 | 0.06947 | miRanda | -0.18 | 0.00154 | NA | |
101 | hsa-miR-362-3p | CCDC85A | 0.11 | 0.64379 | -0.26 | 0.35716 | miRanda; miRNATAP | -0.37 | 1.0E-5 | NA | |
102 | hsa-miR-362-3p | CCDC89 | 0.11 | 0.64379 | -0.04 | 0.849 | miRanda | -0.16 | 0.01666 | NA | |
103 | hsa-miR-362-3p | CCL19 | 0.11 | 0.64379 | -0.2 | 0.71713 | miRanda | -0.49 | 0.00241 | NA | |
104 | hsa-miR-362-3p | CCNJL | 0.11 | 0.64379 | -0.46 | 0.06809 | miRanda | -0.22 | 0.00205 | NA | |
105 | hsa-miR-362-3p | CCPG1 | 0.11 | 0.64379 | -0.39 | 0.02629 | miRanda | -0.12 | 0.00048 | NA | |
106 | hsa-miR-362-3p | CD36 | 0.11 | 0.64379 | -0.56 | 0.10855 | miRanda | -0.36 | 0.00049 | NA | |
107 | hsa-miR-362-3p | CD79B | 0.11 | 0.64379 | -0.28 | 0.39374 | PITA; miRanda | -0.22 | 0.02274 | NA | |
108 | hsa-miR-362-3p | CDH11 | 0.11 | 0.64379 | -0.86 | 0.00288 | miRanda | -0.43 | 0 | NA | |
109 | hsa-miR-362-3p | CDH13 | 0.11 | 0.64379 | -0.45 | 0.02591 | MirTarget; miRanda | -0.19 | 0.0004 | NA | |
110 | hsa-miR-21-3p | CDK14 | 0.06 | 0.84434 | -0.65 | 0.01679 | MirTarget | -0.51 | 1.0E-5 | NA | |
111 | hsa-miR-362-3p | CDYL2 | 0.11 | 0.64379 | -0.42 | 0.08783 | miRanda | -0.28 | 8.0E-5 | NA | |
112 | hsa-miR-362-5p | CEP97 | 0.51 | 0.05114 | -0.26 | 0.02644 | MirTarget | -0.13 | 2.0E-5 | NA | |
113 | hsa-miR-362-3p | CFH | 0.11 | 0.64379 | -0.52 | 0.05574 | miRanda | -0.42 | 0 | NA | |
114 | hsa-miR-21-3p | CHL1 | 0.06 | 0.84434 | -0.75 | 0.06297 | MirTarget | -0.99 | 0 | NA | |
115 | hsa-miR-362-3p | CHL1 | 0.11 | 0.64379 | -0.75 | 0.06297 | miRanda | -0.61 | 0 | NA | |
116 | hsa-miR-362-5p | CHODL | 0.51 | 0.05114 | -0.13 | 0.75219 | PITA | -0.39 | 0.00037 | NA | |
117 | hsa-miR-362-3p | CHRDL1 | 0.11 | 0.64379 | -0.12 | 0.84302 | PITA; miRanda; miRNATAP | -0.88 | 0 | NA | |
118 | hsa-miR-362-5p | CHSY1 | 0.51 | 0.05114 | -0.22 | 0.16771 | MirTarget; PITA; TargetScan; miRNATAP | -0.19 | 0 | NA | |
119 | hsa-miR-362-5p | CIITA | 0.51 | 0.05114 | -0.35 | 0.34967 | mirMAP | -0.47 | 0 | NA | |
120 | hsa-miR-362-3p | CLCF1 | 0.11 | 0.64379 | -0.01 | 0.94286 | miRanda | -0.14 | 0.00726 | NA | |
121 | hsa-miR-362-5p | CLIC4 | 0.51 | 0.05114 | -0.29 | 0.16683 | PITA | -0.27 | 0 | NA | |
122 | hsa-miR-362-3p | CLIP4 | 0.11 | 0.64379 | -0.43 | 0.14009 | miRanda | -0.48 | 0 | NA | |
123 | hsa-miR-362-3p | CLU | 0.11 | 0.64379 | 0.02 | 0.95834 | miRanda | -0.22 | 0.019 | NA | |
124 | hsa-miR-362-3p | CMTM3 | 0.11 | 0.64379 | -0.4 | 0.05724 | miRanda | -0.29 | 0 | NA | |
125 | hsa-miR-362-3p | CNNM1 | 0.11 | 0.64379 | 0.03 | 0.92696 | miRanda | -0.38 | 0.00015 | NA | |
126 | hsa-miR-362-3p | CNPY4 | 0.11 | 0.64379 | -0.17 | 0.22383 | miRanda | -0.12 | 0.00044 | NA | |
127 | hsa-miR-362-3p | CNR1 | 0.11 | 0.64379 | -0.02 | 0.96823 | miRanda | -0.66 | 0 | NA | |
128 | hsa-miR-21-3p | CNRIP1 | 0.06 | 0.84434 | -0.49 | 0.01296 | MirTarget | -0.44 | 0 | NA | |
129 | hsa-miR-21-3p | COBLL1 | 0.06 | 0.84434 | 0.51 | 0.00495 | mirMAP | -0.19 | 0.00182 | NA | |
130 | hsa-miR-362-3p | COL11A1 | 0.11 | 0.64379 | -1.04 | 0.02407 | miRanda | -0.63 | 0 | NA | |
131 | hsa-miR-362-3p | COL13A1 | 0.11 | 0.64379 | -0.36 | 0.15915 | miRanda | -0.15 | 0.04683 | NA | |
132 | hsa-miR-362-3p | COL24A1 | 0.11 | 0.64379 | -1.04 | 0.00275 | miRanda | -0.53 | 0 | NA | |
133 | hsa-miR-362-3p | COL4A1 | 0.11 | 0.64379 | -0.46 | 0.06991 | miRanda | -0.23 | 1.0E-5 | NA | |
134 | hsa-miR-362-3p | COL5A3 | 0.11 | 0.64379 | -0.29 | 0.25685 | miRanda | -0.19 | 0.00776 | NA | |
135 | hsa-miR-362-3p | COL6A3 | 0.11 | 0.64379 | -0.68 | 0.04435 | miRanda | -0.42 | 0 | NA | |
136 | hsa-miR-362-3p | CORIN | 0.11 | 0.64379 | -0.51 | 0.16112 | miRanda | -0.43 | 5.0E-5 | NA | |
137 | hsa-miR-362-5p | CORO2B | 0.51 | 0.05114 | -0.38 | 0.20458 | PITA; TargetScan; miRNATAP | -0.52 | 0 | NA | |
138 | hsa-miR-21-3p | CPEB4 | 0.06 | 0.84434 | -0.14 | 0.38436 | mirMAP | -0.11 | 0.04416 | NA | |
139 | hsa-miR-362-3p | CPEB4 | 0.11 | 0.64379 | -0.14 | 0.38436 | PITA; miRanda; miRNATAP | -0.17 | 0 | NA | |
140 | hsa-miR-362-5p | CPEB4 | 0.51 | 0.05114 | -0.14 | 0.38436 | PITA; TargetScan; miRNATAP | -0.13 | 0.00015 | NA | |
141 | hsa-miR-21-3p | CPLX2 | 0.06 | 0.84434 | 1.42 | 0.00389 | mirMAP | -0.69 | 0.00113 | NA | |
142 | hsa-miR-362-3p | CR2 | 0.11 | 0.64379 | -0.52 | 0.38404 | miRanda | -0.4 | 0.02325 | NA | |
143 | hsa-miR-362-3p | CREB5 | 0.11 | 0.64379 | 0.1 | 0.71971 | PITA | -0.25 | 0.00256 | NA | |
144 | hsa-miR-362-5p | CREB5 | 0.51 | 0.05114 | 0.1 | 0.71971 | PITA | -0.21 | 0.00718 | NA | |
145 | hsa-miR-21-3p | CREBL2 | 0.06 | 0.84434 | -0.17 | 0.22354 | MirTarget | -0.12 | 0.00059 | NA | |
146 | hsa-miR-362-3p | CRIP2 | 0.11 | 0.64379 | -0.59 | 0.00305 | miRanda | -0.22 | 1.0E-5 | NA | |
147 | hsa-miR-362-3p | CRK | 0.11 | 0.64379 | -0.35 | 0.02694 | miRanda | -0.12 | 0.00011 | NA | |
148 | hsa-miR-362-3p | CRMP1 | 0.11 | 0.64379 | -0.15 | 0.5174 | MirTarget; PITA; miRanda; miRNATAP | -0.33 | 0 | NA | |
149 | hsa-miR-362-3p | CSGALNACT1 | 0.11 | 0.64379 | -0.38 | 0.07842 | miRanda | -0.2 | 0.00133 | NA | |
150 | hsa-miR-362-5p | CSMD2 | 0.51 | 0.05114 | -0.86 | 0.00692 | miRNATAP | -0.58 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 135 | 1672 | 4.536e-21 | 2.11e-17 |
2 | NEUROGENESIS | 119 | 1402 | 3.002e-20 | 6.985e-17 |
3 | CELL DEVELOPMENT | 117 | 1426 | 9.556e-19 | 1.482e-15 |
4 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 80 | 788 | 4.041e-18 | 3.761e-15 |
5 | CIRCULATORY SYSTEM DEVELOPMENT | 80 | 788 | 4.041e-18 | 3.761e-15 |
6 | REGULATION OF CELL DIFFERENTIATION | 117 | 1492 | 3.049e-17 | 2.365e-14 |
7 | VASCULATURE DEVELOPMENT | 55 | 469 | 2.265e-15 | 1.505e-12 |
8 | BLOOD VESSEL MORPHOGENESIS | 47 | 364 | 7.059e-15 | 4.106e-12 |
9 | REGULATION OF CELL DEVELOPMENT | 75 | 836 | 3.731e-14 | 1.929e-11 |
10 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 70 | 750 | 4.151e-14 | 1.931e-11 |
11 | RESPONSE TO ENDOGENOUS STIMULUS | 106 | 1450 | 1.272e-13 | 4.934e-11 |
12 | ANGIOGENESIS | 40 | 293 | 1.207e-13 | 4.934e-11 |
13 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 83 | 1021 | 3.36e-13 | 1.196e-10 |
14 | NEURON DIFFERENTIATION | 75 | 874 | 3.598e-13 | 1.196e-10 |
15 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 101 | 1395 | 9.539e-13 | 2.959e-10 |
16 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 88 | 1142 | 1.2e-12 | 3.489e-10 |
17 | REGULATION OF NEURON DIFFERENTIATION | 55 | 554 | 2.308e-12 | 5.965e-10 |
18 | TISSUE DEVELOPMENT | 106 | 1518 | 2.279e-12 | 5.965e-10 |
19 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 121 | 1848 | 3.827e-12 | 9.372e-10 |
20 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 52 | 513 | 4.286e-12 | 9.497e-10 |
21 | CELLULAR COMPONENT MORPHOGENESIS | 74 | 900 | 4.235e-12 | 9.497e-10 |
22 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 68 | 823 | 2.718e-11 | 5.749e-09 |
23 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 65 | 771 | 3.262e-11 | 6.6e-09 |
24 | NEURON DEVELOPMENT | 60 | 687 | 4.773e-11 | 9.253e-09 |
25 | NEURON PROJECTION MORPHOGENESIS | 43 | 402 | 5.867e-11 | 1.092e-08 |
26 | BIOLOGICAL ADHESION | 78 | 1032 | 6.707e-11 | 1.2e-08 |
27 | SKELETAL SYSTEM DEVELOPMENT | 46 | 455 | 8.434e-11 | 1.445e-08 |
28 | CELL PROJECTION ORGANIZATION | 71 | 902 | 8.695e-11 | 1.445e-08 |
29 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 71 | 917 | 1.81e-10 | 2.764e-08 |
30 | LOCOMOTION | 81 | 1114 | 1.841e-10 | 2.764e-08 |
31 | BEHAVIOR | 49 | 516 | 1.818e-10 | 2.764e-08 |
32 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 73 | 957 | 1.924e-10 | 2.797e-08 |
33 | RESPONSE TO LIPID | 69 | 888 | 2.865e-10 | 4.039e-08 |
34 | NEURON PROJECTION DEVELOPMENT | 50 | 545 | 3.93e-10 | 5.378e-08 |
35 | REGULATION OF CELL MORPHOGENESIS | 50 | 552 | 6.103e-10 | 8.114e-08 |
36 | NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 73 | 983 | 6.338e-10 | 8.192e-08 |
37 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 111 | 1784 | 7.393e-10 | 9.297e-08 |
38 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 74 | 1008 | 7.977e-10 | 9.768e-08 |
39 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 87 | 1275 | 8.854e-10 | 1.056e-07 |
40 | RESPONSE TO ALCOHOL | 38 | 362 | 1.333e-09 | 1.55e-07 |
41 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 91 | 1381 | 2.009e-09 | 2.239e-07 |
42 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 90 | 1360 | 2.021e-09 | 2.239e-07 |
43 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 38 | 368 | 2.116e-09 | 2.29e-07 |
44 | REGULATION OF SYSTEM PROCESS | 46 | 507 | 2.876e-09 | 3.042e-07 |
45 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 40 | 408 | 3.591e-09 | 3.713e-07 |
46 | PROTEIN PHOSPHORYLATION | 69 | 944 | 3.74e-09 | 3.783e-07 |
47 | TAXIS | 43 | 464 | 5.092e-09 | 5.041e-07 |
48 | CELL PART MORPHOGENESIS | 52 | 633 | 8.081e-09 | 7.78e-07 |
49 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 41 | 437 | 8.193e-09 | 7.78e-07 |
50 | POSITIVE REGULATION OF GENE EXPRESSION | 105 | 1733 | 9.644e-09 | 8.975e-07 |
51 | REGULATION OF HOMEOSTATIC PROCESS | 41 | 447 | 1.562e-08 | 1.425e-06 |
52 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 70 | 1004 | 1.958e-08 | 1.752e-06 |
53 | REGULATION OF CELL PROLIFERATION | 93 | 1496 | 2.3e-08 | 2.02e-06 |
54 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 34 | 337 | 2.676e-08 | 2.306e-06 |
55 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 63 | 872 | 2.882e-08 | 2.438e-06 |
56 | RESPONSE TO EXTERNAL STIMULUS | 107 | 1821 | 3.429e-08 | 2.849e-06 |
57 | RESPONSE TO STEROID HORMONE | 43 | 497 | 3.811e-08 | 3.111e-06 |
58 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 106 | 1805 | 4.141e-08 | 3.263e-06 |
59 | ORGAN MORPHOGENESIS | 61 | 841 | 4.207e-08 | 3.263e-06 |
60 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 17 | 98 | 4.1e-08 | 3.263e-06 |
61 | REGULATION OF CELL DEATH | 91 | 1472 | 4.313e-08 | 3.29e-06 |
62 | HEART DEVELOPMENT | 41 | 466 | 5.007e-08 | 3.758e-06 |
63 | UROGENITAL SYSTEM DEVELOPMENT | 31 | 299 | 5.922e-08 | 4.374e-06 |
64 | INTRACELLULAR SIGNAL TRANSDUCTION | 95 | 1572 | 6.181e-08 | 4.494e-06 |
65 | SINGLE ORGANISM BEHAVIOR | 36 | 384 | 6.868e-08 | 4.868e-06 |
66 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 30 | 285 | 6.905e-08 | 4.868e-06 |
67 | REGULATION OF TRANSPORT | 105 | 1804 | 7.615e-08 | 5.288e-06 |
68 | REGULATION OF ION TRANSPORT | 47 | 592 | 1.201e-07 | 8.221e-06 |
69 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 40 | 465 | 1.336e-07 | 9.007e-06 |
70 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 69 | 1036 | 1.452e-07 | 9.381e-06 |
71 | REGULATION OF CELL PROJECTION ORGANIZATION | 45 | 558 | 1.436e-07 | 9.381e-06 |
72 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 69 | 1036 | 1.452e-07 | 9.381e-06 |
73 | REGULATION OF BLOOD CIRCULATION | 30 | 295 | 1.482e-07 | 9.444e-06 |
74 | NEGATIVE REGULATION OF CELL COMMUNICATION | 76 | 1192 | 1.889e-07 | 1.188e-05 |
75 | POSITIVE REGULATION OF CELL DEVELOPMENT | 40 | 472 | 1.983e-07 | 1.23e-05 |
76 | REGULATION OF HEART CONTRACTION | 25 | 221 | 2.168e-07 | 1.328e-05 |
77 | RESPONSE TO ACID CHEMICAL | 31 | 319 | 2.545e-07 | 1.538e-05 |
78 | POSITIVE REGULATION OF CELL COMMUNICATION | 91 | 1532 | 2.637e-07 | 1.573e-05 |
79 | CONNECTIVE TISSUE DEVELOPMENT | 23 | 194 | 2.843e-07 | 1.674e-05 |
80 | HEAD DEVELOPMENT | 52 | 709 | 3.112e-07 | 1.81e-05 |
81 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 108 | 1929 | 3.385e-07 | 1.944e-05 |
82 | RESPONSE TO HORMONE | 61 | 893 | 3.426e-07 | 1.944e-05 |
83 | POSITIVE REGULATION OF CELL PROLIFERATION | 57 | 814 | 3.816e-07 | 2.139e-05 |
84 | CELL MOTILITY | 58 | 835 | 3.918e-07 | 2.145e-05 |
85 | LOCALIZATION OF CELL | 58 | 835 | 3.918e-07 | 2.145e-05 |
86 | MULTI MULTICELLULAR ORGANISM PROCESS | 24 | 213 | 4.067e-07 | 2.2e-05 |
87 | BONE DEVELOPMENT | 20 | 156 | 4.8e-07 | 2.567e-05 |
88 | REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY | 25 | 232 | 5.471e-07 | 2.893e-05 |
89 | CELL CELL ADHESION | 46 | 608 | 6.458e-07 | 3.376e-05 |
90 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 95 | 1656 | 6.696e-07 | 3.462e-05 |
91 | OSSIFICATION | 26 | 251 | 7.005e-07 | 3.543e-05 |
92 | REGULATION OF CELL ADHESION | 47 | 629 | 6.932e-07 | 3.543e-05 |
93 | NEURON PROJECTION GUIDANCE | 23 | 205 | 7.624e-07 | 3.814e-05 |
94 | CARTILAGE DEVELOPMENT | 19 | 147 | 8.148e-07 | 4.033e-05 |
95 | EXTRACELLULAR STRUCTURE ORGANIZATION | 29 | 304 | 9.061e-07 | 4.438e-05 |
96 | REGULATION OF MAPK CASCADE | 48 | 660 | 1.139e-06 | 5.521e-05 |
97 | HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 19 | 153 | 1.508e-06 | 7.162e-05 |
98 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 92 | 1618 | 1.502e-06 | 7.162e-05 |
99 | CELLULAR RESPONSE TO LIPID | 37 | 457 | 1.704e-06 | 7.928e-05 |
100 | POSITIVE REGULATION OF LOCOMOTION | 35 | 420 | 1.693e-06 | 7.928e-05 |
101 | TISSUE MORPHOGENESIS | 41 | 533 | 1.743e-06 | 8.032e-05 |
102 | SYNAPTIC SIGNALING | 35 | 424 | 2.099e-06 | 9.575e-05 |
103 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 54 | 801 | 2.463e-06 | 0.0001113 |
104 | REGULATION OF DENDRITIC SPINE DEVELOPMENT | 11 | 56 | 2.87e-06 | 0.0001284 |
105 | NEGATIVE REGULATION OF CELL PROLIFERATION | 46 | 643 | 2.974e-06 | 0.0001318 |
106 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 28 | 306 | 3.15e-06 | 0.0001381 |
107 | MUSCLE STRUCTURE DEVELOPMENT | 35 | 432 | 3.195e-06 | 0.0001381 |
108 | POSITIVE REGULATION OF CELL DEATH | 44 | 605 | 3.205e-06 | 0.0001381 |
109 | CELL CELL SIGNALING | 52 | 767 | 3.234e-06 | 0.0001381 |
110 | POSITIVE REGULATION OF MAPK CASCADE | 37 | 470 | 3.281e-06 | 0.0001388 |
111 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 12 | 68 | 3.349e-06 | 0.0001404 |
112 | REGULATION OF METAL ION TRANSPORT | 29 | 325 | 3.474e-06 | 0.0001443 |
113 | NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 26 | 274 | 3.636e-06 | 0.0001497 |
114 | REGULATION OF CALCIUM ION TRANSPORT | 22 | 209 | 3.822e-06 | 0.000156 |
115 | SENSORY ORGAN DEVELOPMENT | 38 | 493 | 3.979e-06 | 0.0001596 |
116 | REGULATION OF DENDRITE DEVELOPMENT | 16 | 120 | 3.952e-06 | 0.0001596 |
117 | TUBE DEVELOPMENT | 41 | 552 | 4.163e-06 | 0.0001655 |
118 | REGULATION OF SEQUESTERING OF CALCIUM ION | 15 | 107 | 4.201e-06 | 0.0001657 |
119 | CIRCULATORY SYSTEM PROCESS | 31 | 366 | 4.742e-06 | 0.0001854 |
120 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 53 | 799 | 4.885e-06 | 0.0001894 |
121 | LOCOMOTORY BEHAVIOR | 20 | 181 | 5.013e-06 | 0.0001928 |
122 | SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION | 33 | 404 | 5.121e-06 | 0.0001953 |
123 | NEGATIVE REGULATION OF LOCOMOTION | 25 | 263 | 5.402e-06 | 0.0002044 |
124 | DEVELOPMENTAL GROWTH | 29 | 333 | 5.593e-06 | 0.0002099 |
125 | MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY | 11 | 60 | 5.824e-06 | 0.0002168 |
126 | REGULATION OF TRANSMEMBRANE TRANSPORT | 34 | 426 | 6.096e-06 | 0.0002251 |
127 | POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 18 | 154 | 6.734e-06 | 0.0002467 |
128 | CELL JUNCTION ORGANIZATION | 20 | 185 | 6.989e-06 | 0.0002521 |
129 | GROWTH | 33 | 410 | 6.987e-06 | 0.0002521 |
130 | SKELETAL SYSTEM MORPHOGENESIS | 21 | 201 | 7.099e-06 | 0.0002541 |
131 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 68 | 1135 | 7.393e-06 | 0.0002626 |
132 | NEGATIVE REGULATION OF CELL DEVELOPMENT | 27 | 303 | 7.689e-06 | 0.0002711 |
133 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 56 | 876 | 7.848e-06 | 0.0002745 |
134 | REGULATION OF SYNAPSE ORGANIZATION | 15 | 113 | 8.323e-06 | 0.0002848 |
135 | REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION | 21 | 203 | 8.283e-06 | 0.0002848 |
136 | PHOSPHORYLATION | 72 | 1228 | 8.256e-06 | 0.0002848 |
137 | NEGATIVE REGULATION OF CELL DIFFERENTIATION | 43 | 609 | 8.675e-06 | 0.0002946 |
138 | TUBE MORPHOGENESIS | 28 | 323 | 8.813e-06 | 0.0002971 |
139 | EPITHELIUM DEVELOPMENT | 59 | 945 | 9.119e-06 | 0.0003053 |
140 | SENSORY PERCEPTION OF PAIN | 12 | 75 | 9.628e-06 | 0.00032 |
141 | RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 6 | 16 | 1.007e-05 | 0.0003324 |
142 | RESPONSE TO GROWTH FACTOR | 36 | 475 | 1.033e-05 | 0.0003386 |
143 | EYE DEVELOPMENT | 28 | 326 | 1.047e-05 | 0.0003407 |
144 | CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL | 9 | 42 | 1.093e-05 | 0.0003507 |
145 | CALCIUM ION IMPORT INTO CYTOSOL | 9 | 42 | 1.093e-05 | 0.0003507 |
146 | CYTOSOLIC CALCIUM ION TRANSPORT | 10 | 53 | 1.184e-05 | 0.0003774 |
147 | RESPONSE TO OXYGEN LEVELS | 27 | 311 | 1.236e-05 | 0.0003913 |
148 | ENDOTHELIUM DEVELOPMENT | 13 | 90 | 1.308e-05 | 0.0004113 |
149 | MUSCLE ORGAN DEVELOPMENT | 25 | 277 | 1.332e-05 | 0.0004161 |
150 | CELL FATE COMMITMENT | 22 | 227 | 1.442e-05 | 0.0004474 |
151 | REGULATION OF CARDIAC CONDUCTION | 11 | 66 | 1.512e-05 | 0.0004658 |
152 | RESPONSE TO FLUID SHEAR STRESS | 8 | 34 | 1.629e-05 | 0.0004988 |
153 | REGULATION OF CHEMOTAXIS | 19 | 180 | 1.658e-05 | 0.0005044 |
154 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 11 | 67 | 1.753e-05 | 0.0005296 |
155 | RESPONSE TO NITROGEN COMPOUND | 54 | 859 | 1.827e-05 | 0.0005449 |
156 | ADULT BEHAVIOR | 16 | 135 | 1.815e-05 | 0.0005449 |
157 | REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 57 | 926 | 1.953e-05 | 0.0005787 |
158 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 82 | 1492 | 2.063e-05 | 0.0006076 |
159 | REGULATION OF AXONOGENESIS | 18 | 168 | 2.246e-05 | 0.0006574 |
160 | REGULATION OF ION HOMEOSTASIS | 20 | 201 | 2.391e-05 | 0.0006952 |
161 | REGULATION OF BLOOD PRESSURE | 18 | 169 | 2.435e-05 | 0.0007036 |
162 | REGULATION OF MEMBRANE POTENTIAL | 28 | 343 | 2.656e-05 | 0.000758 |
163 | DIVALENT INORGANIC CATION HOMEOSTASIS | 28 | 343 | 2.656e-05 | 0.000758 |
164 | REGULATION OF DEVELOPMENTAL GROWTH | 25 | 289 | 2.732e-05 | 0.0007752 |
165 | PROTEOGLYCAN METABOLIC PROCESS | 12 | 83 | 2.773e-05 | 0.0007819 |
166 | CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES | 20 | 204 | 2.962e-05 | 0.0008302 |
167 | POSITIVE REGULATION OF OSSIFICATION | 12 | 84 | 3.135e-05 | 0.0008734 |
168 | POSITIVE REGULATION OF KINASE ACTIVITY | 35 | 482 | 3.35e-05 | 0.0009278 |
169 | RESPONSE TO WOUNDING | 39 | 563 | 3.464e-05 | 0.0009537 |
170 | ENDOTHELIAL CELL DIFFERENTIATION | 11 | 72 | 3.524e-05 | 0.0009644 |
171 | NEGATIVE REGULATION OF NEURON DIFFERENTIATION | 19 | 191 | 3.808e-05 | 0.001036 |
172 | SECRETION BY CELL | 35 | 486 | 3.968e-05 | 0.001073 |
173 | SECRETION | 40 | 588 | 4.13e-05 | 0.001111 |
174 | RESPONSE TO CORTICOSTEROID | 18 | 176 | 4.195e-05 | 0.001122 |
175 | RESPONSE TO CALCIUM ION | 14 | 115 | 4.437e-05 | 0.00118 |
176 | NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 23 | 262 | 4.51e-05 | 0.001192 |
177 | ACTIN FILAMENT BASED PROCESS | 33 | 450 | 4.61e-05 | 0.001205 |
178 | REGULATION OF EXTENT OF CELL GROWTH | 13 | 101 | 4.584e-05 | 0.001205 |
179 | NEGATIVE CHEMOTAXIS | 8 | 39 | 4.738e-05 | 0.001232 |
180 | REGULATION OF OSSIFICATION | 18 | 178 | 4.872e-05 | 0.001259 |
181 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 93 | 1791 | 4.929e-05 | 0.001263 |
182 | RESPONSE TO ABIOTIC STIMULUS | 60 | 1024 | 4.94e-05 | 0.001263 |
183 | REGULATION OF RESPONSE TO WOUNDING | 31 | 413 | 5.046e-05 | 0.001276 |
184 | CARDIOBLAST DIFFERENTIATION | 5 | 13 | 5.026e-05 | 0.001276 |
185 | REGULATION OF SECRETION | 45 | 699 | 5.249e-05 | 0.00132 |
186 | MODULATION OF SYNAPTIC TRANSMISSION | 25 | 301 | 5.346e-05 | 0.001337 |
187 | EMBRYO DEVELOPMENT | 54 | 894 | 5.375e-05 | 0.001338 |
188 | REGULATION OF CARTILAGE DEVELOPMENT | 10 | 63 | 5.684e-05 | 0.001392 |
189 | PEPTIDYL SERINE MODIFICATION | 16 | 148 | 5.672e-05 | 0.001392 |
190 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 13 | 103 | 5.644e-05 | 0.001392 |
191 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 46 | 724 | 5.947e-05 | 0.001449 |
192 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 21 | 232 | 6.148e-05 | 0.00149 |
193 | REGULATION OF CELL MATRIX ADHESION | 12 | 90 | 6.289e-05 | 0.001516 |
194 | REGULATION OF CELL CELL ADHESION | 29 | 380 | 6.526e-05 | 0.001565 |
195 | RESPONSE TO INORGANIC SUBSTANCE | 34 | 479 | 6.784e-05 | 0.001619 |
196 | MATERNAL PLACENTA DEVELOPMENT | 7 | 31 | 7.397e-05 | 0.001756 |
197 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 44 | 689 | 7.643e-05 | 0.001805 |
198 | RESPONSE TO ALKALOID | 15 | 137 | 8.298e-05 | 0.00195 |
199 | REGULATION OF SYNAPSE ASSEMBLY | 11 | 79 | 8.461e-05 | 0.001969 |
200 | BONE MORPHOGENESIS | 11 | 79 | 8.461e-05 | 0.001969 |
201 | REGULATION OF GROWTH | 41 | 633 | 9.848e-05 | 0.00228 |
202 | REGULATION OF CELL SIZE | 17 | 172 | 0.000104 | 0.002396 |
203 | NEGATIVE REGULATION OF RESPONSE TO WOUNDING | 16 | 156 | 0.0001066 | 0.002444 |
204 | CELLULAR RESPONSE TO HORMONE STIMULUS | 37 | 552 | 0.0001077 | 0.002445 |
205 | REGULATION OF CELL GROWTH | 29 | 391 | 0.0001077 | 0.002445 |
206 | ORGAN GROWTH | 10 | 68 | 0.0001107 | 0.002476 |
207 | CELLULAR RESPONSE TO STEROL | 5 | 15 | 0.0001107 | 0.002476 |
208 | REGULATION OF PROTEIN MODIFICATION PROCESS | 88 | 1710 | 0.0001098 | 0.002476 |
209 | STEM CELL DIFFERENTIATION | 18 | 190 | 0.0001136 | 0.00253 |
210 | REGULATION OF ANATOMICAL STRUCTURE SIZE | 33 | 472 | 0.0001151 | 0.00255 |
211 | POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT | 9 | 56 | 0.0001205 | 0.002656 |
212 | ION HOMEOSTASIS | 38 | 576 | 0.000121 | 0.002656 |
213 | SYNAPSE ASSEMBLY | 10 | 69 | 0.0001255 | 0.002741 |
214 | EPITHELIAL CELL DIFFERENTIATION | 34 | 495 | 0.000128 | 0.002783 |
215 | CELLULAR RESPONSE TO ACID CHEMICAL | 17 | 175 | 0.0001286 | 0.002784 |
216 | FOREBRAIN DEVELOPMENT | 27 | 357 | 0.0001339 | 0.002857 |
217 | RESPONSE TO STEROL | 6 | 24 | 0.0001336 | 0.002857 |
218 | CALCIUM ION TRANSMEMBRANE TRANSPORT | 16 | 159 | 0.0001335 | 0.002857 |
219 | CYCLIC NUCLEOTIDE METABOLIC PROCESS | 9 | 57 | 0.0001387 | 0.002921 |
220 | CAMP METABOLIC PROCESS | 7 | 34 | 0.0001383 | 0.002921 |
221 | ENDOCHONDRAL BONE MORPHOGENESIS | 8 | 45 | 0.0001382 | 0.002921 |
222 | EMBRYONIC MORPHOGENESIS | 36 | 539 | 0.0001427 | 0.00299 |
223 | REGULATION OF HORMONE LEVELS | 33 | 478 | 0.0001457 | 0.00304 |
224 | REGULATION OF STEM CELL DIFFERENTIATION | 13 | 113 | 0.0001476 | 0.003065 |
225 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 24 | 303 | 0.0001556 | 0.003218 |
226 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 13 | 114 | 0.0001614 | 0.003322 |
227 | RESPONSE TO ESTRADIOL | 15 | 146 | 0.0001702 | 0.00349 |
228 | POSITIVE REGULATION OF TRANSPORT | 54 | 936 | 0.0001748 | 0.003567 |
229 | CELLULAR RESPONSE TO ALCOHOL | 13 | 115 | 0.0001763 | 0.003582 |
230 | REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 18 | 197 | 0.0001795 | 0.003631 |
231 | REGULATION OF GTPASE ACTIVITY | 42 | 673 | 0.0001823 | 0.003672 |
232 | COGNITION | 21 | 251 | 0.000187 | 0.00375 |
233 | REGULATION OF VASCULATURE DEVELOPMENT | 20 | 233 | 0.0001878 | 0.00375 |
234 | CHEMICAL HOMEOSTASIS | 51 | 874 | 0.0002015 | 0.004008 |
235 | EMBRYONIC ORGAN DEVELOPMENT | 29 | 406 | 0.0002051 | 0.004061 |
236 | CHONDROCYTE DIFFERENTIATION | 9 | 60 | 0.0002079 | 0.004081 |
237 | POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION | 9 | 60 | 0.0002079 | 0.004081 |
238 | CYCLIC NUCLEOTIDE CATABOLIC PROCESS | 5 | 17 | 0.0002153 | 0.004141 |
239 | REGULATION OF ENERGY HOMEOSTASIS | 5 | 17 | 0.0002153 | 0.004141 |
240 | REPLACEMENT OSSIFICATION | 6 | 26 | 0.0002154 | 0.004141 |
241 | ENDOCHONDRAL OSSIFICATION | 6 | 26 | 0.0002154 | 0.004141 |
242 | POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 6 | 26 | 0.0002154 | 0.004141 |
243 | REGULATION OF EPITHELIAL CELL MIGRATION | 16 | 166 | 0.0002201 | 0.004214 |
244 | REGULATION OF DENDRITE MORPHOGENESIS | 10 | 74 | 0.000227 | 0.004329 |
245 | POSITIVE REGULATION OF SYNAPSE ASSEMBLY | 9 | 61 | 0.0002365 | 0.004472 |
246 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 17 | 184 | 0.0002356 | 0.004472 |
247 | REGULATION OF ACTIN FILAMENT BASED PROCESS | 24 | 312 | 0.0002414 | 0.004547 |
248 | POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE | 14 | 135 | 0.0002519 | 0.004727 |
249 | REGULATION OF HEMOPOIESIS | 24 | 314 | 0.0002653 | 0.004958 |
250 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 97 | 1977 | 0.0002696 | 0.005003 |
251 | POSITIVE REGULATION OF CHEMOTAXIS | 13 | 120 | 0.0002699 | 0.005003 |
252 | REGULATION OF CELLULAR LOCALIZATION | 68 | 1277 | 0.000272 | 0.005023 |
253 | POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS | 23 | 296 | 0.0002794 | 0.005138 |
254 | LEUKOCYTE ACTIVATION | 29 | 414 | 0.0002842 | 0.005206 |
255 | RETINAL GANGLION CELL AXON GUIDANCE | 5 | 18 | 0.0002897 | 0.005286 |
256 | REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC | 8 | 50 | 0.0002956 | 0.005373 |
257 | AMEBOIDAL TYPE CELL MIGRATION | 15 | 154 | 0.0003058 | 0.005537 |
258 | RHYTHMIC PROCESS | 23 | 298 | 0.0003076 | 0.005548 |
259 | REGULATION OF CELLULAR COMPONENT SIZE | 25 | 337 | 0.0003137 | 0.005636 |
260 | NEUROTRANSMITTER TRANSPORT | 15 | 155 | 0.000328 | 0.00587 |
261 | POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE | 6 | 28 | 0.0003322 | 0.005922 |
262 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 14 | 140 | 0.0003672 | 0.006516 |
263 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 44 | 740 | 0.0003683 | 0.006516 |
264 | CALCIUM ION IMPORT | 9 | 65 | 0.0003855 | 0.006794 |
265 | CELL ACTIVATION | 36 | 568 | 0.0003888 | 0.006801 |
266 | REGULATION OF FEVER GENERATION | 4 | 11 | 0.0003882 | 0.006801 |
267 | RESPONSE TO MECHANICAL STIMULUS | 18 | 210 | 0.0003935 | 0.006857 |
268 | REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION | 6 | 29 | 0.0004067 | 0.007061 |
269 | NEURON MIGRATION | 12 | 110 | 0.0004308 | 0.00743 |
270 | REGULATION OF JNK CASCADE | 15 | 159 | 0.0004311 | 0.00743 |
271 | HEART MORPHOGENESIS | 18 | 212 | 0.0004409 | 0.007571 |
272 | RAS PROTEIN SIGNAL TRANSDUCTION | 14 | 143 | 0.0004559 | 0.007799 |
273 | REGULATION OF JUN KINASE ACTIVITY | 10 | 81 | 0.0004778 | 0.008144 |
274 | REGULATION OF LEUKOCYTE DIFFERENTIATION | 19 | 232 | 0.0004854 | 0.008243 |
275 | REGULATION OF OSTEOBLAST DIFFERENTIATION | 12 | 112 | 0.0005081 | 0.008567 |
276 | POSITIVE REGULATION OF LIPID METABOLIC PROCESS | 13 | 128 | 0.000507 | 0.008567 |
277 | SYNAPSE ORGANIZATION | 14 | 145 | 0.0005248 | 0.008798 |
278 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 15 | 162 | 0.0005257 | 0.008798 |
279 | CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 4 | 12 | 0.0005663 | 0.009411 |
280 | CELLULAR RESPONSE TO CHOLESTEROL | 4 | 12 | 0.0005663 | 0.009411 |
281 | REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION | 6 | 31 | 0.0005943 | 0.009841 |
282 | REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY | 12 | 114 | 0.0005968 | 0.009847 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 51 | 629 | 1.736e-08 | 1.613e-05 |
2 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 30 | 315 | 6.098e-07 | 0.0001888 |
3 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 75 | 1199 | 4.81e-07 | 0.0001888 |
4 | PROTEIN KINASE ACTIVITY | 46 | 640 | 2.625e-06 | 0.0006095 |
5 | REGULATORY REGION NUCLEIC ACID BINDING | 54 | 818 | 4.564e-06 | 0.0007067 |
6 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 23 | 226 | 4.108e-06 | 0.0007067 |
7 | GLYCOSAMINOGLYCAN BINDING | 21 | 205 | 9.643e-06 | 0.0009953 |
8 | RECEPTOR SIGNALING PROTEIN ACTIVITY | 19 | 172 | 8.63e-06 | 0.0009953 |
9 | RECEPTOR BINDING | 83 | 1476 | 7.882e-06 | 0.0009953 |
10 | CALCIUM ION BINDING | 46 | 697 | 2.364e-05 | 0.002196 |
11 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 27 | 328 | 3.183e-05 | 0.002688 |
12 | SIGNAL TRANSDUCER ACTIVITY | 91 | 1731 | 3.812e-05 | 0.002951 |
13 | PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY | 33 | 464 | 8.328e-05 | 0.005951 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NEURON PART | 102 | 1265 | 7.486e-16 | 4.372e-13 |
2 | NEURON PROJECTION | 79 | 942 | 2.655e-13 | 7.752e-11 |
3 | SYNAPSE | 67 | 754 | 1.488e-12 | 2.897e-10 |
4 | SOMATODENDRITIC COMPARTMENT | 60 | 650 | 4.896e-12 | 7.148e-10 |
5 | SYNAPSE PART | 55 | 610 | 9.696e-11 | 1.132e-08 |
6 | CELL PROJECTION | 113 | 1786 | 1.862e-10 | 1.812e-08 |
7 | CELL JUNCTION | 81 | 1151 | 8.692e-10 | 7.251e-08 |
8 | DENDRITE | 43 | 451 | 2.162e-09 | 1.578e-07 |
9 | CELL BODY | 44 | 494 | 1.117e-08 | 6.602e-07 |
10 | MEMBRANE REGION | 77 | 1134 | 1.13e-08 | 6.602e-07 |
11 | POSTSYNAPSE | 36 | 378 | 4.611e-08 | 2.448e-06 |
12 | AXON | 38 | 418 | 6.667e-08 | 3.245e-06 |
13 | EXCITATORY SYNAPSE | 24 | 197 | 9.376e-08 | 3.911e-06 |
14 | MEMBRANE MICRODOMAIN | 30 | 288 | 8.719e-08 | 3.911e-06 |
15 | CELL SURFACE | 55 | 757 | 1.904e-07 | 7.411e-06 |
16 | EXTRACELLULAR MATRIX | 36 | 426 | 8.666e-07 | 3.163e-05 |
17 | PROTEINACEOUS EXTRACELLULAR MATRIX | 32 | 356 | 9.33e-07 | 3.205e-05 |
18 | PRESYNAPSE | 27 | 283 | 2.139e-06 | 6.941e-05 |
19 | SECRETORY VESICLE | 36 | 461 | 5.331e-06 | 0.0001588 |
20 | PLASMA MEMBRANE REGION | 59 | 929 | 5.438e-06 | 0.0001588 |
21 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 91 | 1649 | 5.865e-06 | 0.0001631 |
22 | EXOCYTIC VESICLE | 16 | 142 | 3.416e-05 | 0.0009067 |
23 | SECRETORY GRANULE | 27 | 352 | 0.000106 | 0.002318 |
24 | EXTRACELLULAR MATRIX COMPONENT | 14 | 125 | 0.0001111 | 0.002318 |
25 | EXTRACELLULAR SPACE | 74 | 1376 | 0.0001069 | 0.002318 |
26 | SARCOLEMMA | 14 | 125 | 0.0001111 | 0.002318 |
27 | CELL LEADING EDGE | 27 | 350 | 9.644e-05 | 0.002318 |
28 | PLASMA MEMBRANE PROTEIN COMPLEX | 35 | 510 | 0.000104 | 0.002318 |
29 | CELL CELL JUNCTION | 28 | 383 | 0.0001791 | 0.003607 |
30 | VESICLE LUMEN | 12 | 106 | 0.0003056 | 0.005949 |
31 | BASEMENT MEMBRANE | 11 | 93 | 0.0003686 | 0.006943 |
32 | CELL PROJECTION PART | 53 | 946 | 0.0004055 | 0.007401 |
33 | NEURONAL POSTSYNAPTIC DENSITY | 8 | 53 | 0.0004455 | 0.007884 |
34 | PLATELET ALPHA GRANULE LUMEN | 8 | 55 | 0.000576 | 0.00961 |
35 | CYTOPLASMIC VESICLE PART | 37 | 601 | 0.0005608 | 0.00961 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Apelin_signaling_pathway_hsa04371 | 18 | 137 | 1.241e-06 | 6.451e-05 | |
2 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 15 | 139 | 9.792e-05 | 0.002315 | |
3 | cGMP_PKG_signaling_pathway_hsa04022 | 16 | 163 | 0.0001783 | 0.002315 | |
4 | Calcium_signaling_pathway_hsa04020 | 17 | 182 | 0.0002068 | 0.002315 | |
5 | MAPK_signaling_pathway_hsa04010 | 23 | 295 | 0.0002661 | 0.002315 | |
6 | Hippo_signaling_pathway_hsa04390 | 15 | 154 | 0.0003058 | 0.002315 | |
7 | Rap1_signaling_pathway_hsa04015 | 18 | 206 | 0.0003117 | 0.002315 | |
8 | Hippo_signaling_pathway_multiple_species_hsa04392 | 6 | 29 | 0.0004067 | 0.002644 | |
9 | Gap_junction_hsa04540 | 10 | 88 | 0.0009248 | 0.005343 | |
10 | ECM_receptor_interaction_hsa04512 | 9 | 82 | 0.0021 | 0.01092 | |
11 | Regulation_of_actin_cytoskeleton_hsa04810 | 16 | 208 | 0.002497 | 0.0118 | |
12 | Cytokine_cytokine_receptor_interaction_hsa04060 | 19 | 270 | 0.002867 | 0.01242 | |
13 | cAMP_signaling_pathway_hsa04024 | 15 | 198 | 0.003872 | 0.01507 | |
14 | Focal_adhesion_hsa04510 | 15 | 199 | 0.004058 | 0.01507 | |
15 | Cell_adhesion_molecules_.CAMs._hsa04514 | 12 | 145 | 0.004644 | 0.0161 | |
16 | Ras_signaling_pathway_hsa04014 | 16 | 232 | 0.00715 | 0.02324 | |
17 | Phospholipase_D_signaling_pathway_hsa04072 | 11 | 146 | 0.01285 | 0.03931 | |
18 | NF_kappa_B_signaling_pathway_hsa04064 | 8 | 95 | 0.01729 | 0.04995 | |
19 | PI3K_Akt_signaling_pathway_hsa04151 | 20 | 352 | 0.0215 | 0.05886 | |
20 | TGF_beta_signaling_pathway_hsa04350 | 7 | 84 | 0.02645 | 0.06876 | |
21 | Autophagy_animal_hsa04140 | 9 | 128 | 0.03411 | 0.08447 | |
22 | Jak_STAT_signaling_pathway_hsa04630 | 10 | 162 | 0.05581 | 0.1319 | |
23 | AMPK_signaling_pathway_hsa04152 | 8 | 121 | 0.0595 | 0.1321 | |
24 | Neuroactive_ligand_receptor_interaction_hsa04080 | 15 | 278 | 0.06098 | 0.1321 | |
25 | Oocyte_meiosis_hsa04114 | 8 | 124 | 0.0667 | 0.1387 | |
26 | ABC_transporters_hsa02010 | 4 | 45 | 0.06968 | 0.1394 | |
27 | FoxO_signaling_pathway_hsa04068 | 8 | 132 | 0.08842 | 0.1703 | |
28 | Adherens_junction_hsa04520 | 5 | 72 | 0.1042 | 0.1935 | |
29 | mTOR_signaling_pathway_hsa04150 | 8 | 151 | 0.1544 | 0.2768 | |
30 | ErbB_signaling_pathway_hsa04012 | 5 | 85 | 0.1721 | 0.2984 | |
31 | Cellular_senescence_hsa04218 | 8 | 160 | 0.192 | 0.322 | |
32 | Endocytosis_hsa04144 | 11 | 244 | 0.2276 | 0.3617 | |
33 | Notch_signaling_pathway_hsa04330 | 3 | 48 | 0.2314 | 0.3617 | |
34 | Tight_junction_hsa04530 | 8 | 170 | 0.2377 | 0.3617 | |
35 | Wnt_signaling_pathway_hsa04310 | 7 | 146 | 0.2435 | 0.3617 | |
36 | Autophagy_other_hsa04136 | 2 | 32 | 0.3049 | 0.4404 | |
37 | VEGF_signaling_pathway_hsa04370 | 3 | 59 | 0.3355 | 0.4715 | |
38 | Phagosome_hsa04145 | 6 | 152 | 0.4317 | 0.5908 | |
39 | HIF_1_signaling_pathway_hsa04066 | 4 | 100 | 0.4578 | 0.6104 | |
40 | Hedgehog_signaling_pathway_hsa04340 | 2 | 47 | 0.488 | 0.6344 | |
41 | Apoptosis_hsa04210 | 5 | 138 | 0.5234 | 0.6638 | |
42 | Mitophagy_animal_hsa04137 | 2 | 65 | 0.6637 | 0.8121 | |
43 | Phosphatidylinositol_signaling_system_hsa04070 | 3 | 99 | 0.6716 | 0.8121 | |
44 | p53_signaling_pathway_hsa04115 | 2 | 68 | 0.6877 | 0.8128 | |
45 | TNF_signaling_pathway_hsa04668 | 3 | 108 | 0.7275 | 0.8407 | |
46 | Lysosome_hsa04142 | 3 | 123 | 0.8038 | 0.9086 | |
47 | Sphingolipid_signaling_pathway_hsa04071 | 2 | 118 | 0.919 | 0.9846 | |
48 | Necroptosis_hsa04217 | 3 | 164 | 0.9266 | 0.9846 | |
49 | Cell_cycle_hsa04110 | 2 | 124 | 0.9318 | 0.9846 |